Remission in Cancer: meaning, types, and its impact on recovery

Remission in cancer is a fundamental concept that represents a ray of hope for patients and their families. This term refers to the decrease or disappearance of the signs and symptoms of cancer, marking a significant milestone in the treatment of the disease.

Understanding what remission means, its different types and what it means for the patient is fundamental for those on the road to recovery. This article aims to clarify these aspects so that patients and their families can navigate this process with greater confidence and knowledge.

 

What is remission in cancer?

In oncology, remission refers to the reduction or disappearance of the signs and symptoms of cancer. It is important to distinguish between the reduction of symptoms and the total absence of cancer. Remission can be partial, where some signs and symptoms disappear, or complete, where no signs of cancer are detected in the body.

Difference between remission and cure

Although remission is a positive step, it is important to clarify that it does not always mean a cure. Complete remission indicates that there are no detectable signs of cancer, but the cancer cells may remain in the body and cause a recurrence. In medicine, it is preferable to use the term ‘complete remission’ rather than ‘cure’ because of the possibility of the cancer returning.

 

Types of remission

Partial remission

Partial remission means that the cancer has decreased significantly but has not completely disappeared. It is detected by imaging tests and other diagnostic methods and may involve adjustments to the treatment. It is common in certain types of cancer, such as lymphoma and some breast cancers.

Complete remission

Complete remission is defined as the total absence of signs and symptoms of cancer. Screening methods include imaging tests, blood tests and tumour markers. Although this is a significant achievement, there is a possibility that the cancer may return even after a complete remission.

 

Factors influencing cancer remission

Cancer remission can be influenced by a variety of factors, including the type and stage of the cancer, response to treatment and individual factors such as genetics, lifestyle choices and the immune system.

Importance of cancer type and stage at diagnosis

The type of cancer and its stage at diagnosis are key determinants of remission. The staging of cancer refers to the extent of the disease in the body, including the size of the tumour and whether it has spread to other parts of the body. Cancers in earlier stages tend to have better remission rates as they are easier to treat and control. For example, a cancer detected at stage I is more likely to go into complete remission compared to one at stage IV.

Response to treatment

The effectiveness of treatments such as chemotherapy, radiotherapy, immunotherapy and surgery plays a fundamental role in the remission of cancer. Response to treatment can vary significantly between patients, even those with the same type of cancer. Some treatments can reduce the size of the tumour or eliminate it completely, while others may not be as effective. The combination of different treatments can also improve the chances of remission

Individual factors: genetics, lifestyle and immune system

  • Genetics: genetic predisposition can affect response to treatment and the likelihood of remission. Some people may have genetic mutations that make their cancer cells more resistant to certain treatments.
  • Lifestyle: healthy habits such as a balanced diet, regular exercise and avoiding smoking and alcohol consumption can improve the response to treatment and reduce the risk of recurrence. In addition, a healthy lifestyle can strengthen the immune system, helping the body to fight cancer more effectively.
  • Immune system: a strong immune system can help to control and eliminate cancer cells. Immunological therapies, which stimulate the immune system to attack the cancer, have shown promising results in the remission of certain types of cancer.

 

Follow-up and control after remission

Examinations and control tests

Physical examinations: regular physical examinations are an essential part of post-remission follow-up. During these visits, the doctor will assess the patient’s general state of health, look for signs of cancer recurrence and address any new or persistent symptoms. It is recommended that these check-ups take place every 3 to 4 months during the first 2 to 3 years after treatment, and then be spaced out to once or twice a year until the age of 5, becoming annual thereafter, depending on the type of tumour.

Blood tests: blood tests are important tools for monitoring the patient’s health and detecting early signs of recurrence. These may include:

  • Complete blood count: to assess red blood cell, white blood cell and platelet levels.
  • Liver and kidney function tests: to ensure that these organs are functioning properly.
  • Tumour markers: substances that may be present in high levels if the cancer has returned, however, tumour markers can be elevated for other reasons such as impaired liver or kidney function, smoking… so their values should always be interpreted by a specialist.

 

Imaging tests

Imaging tests are crucial for visualising the inside of the body and detecting any abnormalities that may indicate a recurrence of the cancer. The most common tests include:

  • X-rays: used to detect changes in the bones and lungs.
  • Computed tomography (CT): provides detailed images of internal organs.
  • Magnetic resonance imaging (MRI): used to obtain detailed images of soft tissue.
  • Positron emission tomography (PET): helps to identify areas of abnormal metabolic activity that may indicate the presence of cancer.

 

Specific tests depending on the type of cancer

Depending on the type of cancer the patient has had, additional tests may be necessary. For example:

  • Mammograms: for breast cancer patients.
  • Colonoscopies: for those who have had colon cancer.
  • Gastroscopy: for patients who have had oesophageal or stomach cancer
  • Cervical ultrasound: for patients with thyroid, parathyroid and parotid gland cancer.
  • Bone scintigraphy to assess bone metastases: for example, from breast or prostate cancer.
  • CT and MRI of the brain to monitor brain metastases
  • Cytology and HPV tests: for women who have had cervical cancer and for patients with anal cancer.

 

Monitoring for long-term side effects

Cancer treatment can cause side effects that appear months or even years after the end of treatment. These are known as late effects and include heart, lung, neurological, hormonal and fertility problems, among others. It is important that patients inform their doctors about any new or worrying symptoms so that they can receive appropriate care.

Emotional and psychological support

Medical follow-up should also include emotional and psychological support. Cancer survivors may experience anxiety, depression and other emotional problems such as cancer phobia or fear of a second cancer or recurrence of the primary or development of metastasis. Talking about these issues with a mental health professional can be very beneficial, such as our team of psycho-oncologists.

Lifestyle and prevention

Maintaining a healthy lifestyle is essential to reduce the risk of relapse. A balanced diet, regular exercise and avoiding harmful habits such as smoking and alcohol consumption are recommended. In addition, psychological and emotional support is vital for cancer survivors.

 

What to do if the cancer returns?

Cancer recurrence occurs when cancer cells that remained in the body after initial treatment start to grow again. This can happen in the same place where the cancer originated (local recurrence), in nearby lymph nodes (regional recurrence) or in a distant part of the body (distant recurrence or metastasis).

The impact of the news can be a very challenging experience for the patient. It is important to understand the available treatment options and to seek medical and psychological support. Treatments may include a combination of previously used therapies or new strategies based on available medical advances.

 

In short, remission in cancer is a crucial step on the road to recovery. In this sense, it is a term that indicates that we can maintain cautious optimism about the clinical situation. Although it does not always mean a cure, it offers hope and a better quality of life for patients. Proper medical follow-up and a healthy lifestyle are essential to maintain remission and prevent recurrence.

Dr. Rosa María Morera

Radiation Oncology

  • Specialist in Radiation Oncology.
  • Degree in Medicine and Surgery.  Faculty of Medicine, Complutense University of Madrid (2-8-1990).
  • Head of the Radiation Oncology Department, Hospital Universitario La Paz, Madrid.
  • Expert with university micro-credential mention in Physics, Technology and Protontherapy. King Juan Carlos University.
  • Higher University Course in Design and Management of Proton Therapy Centres. King Juan Carlos University.
  • XIX Programme of Senior Management in Health Institutions. IESE Business School. University of Navarra.
  • Master in Administration and Management of Health Services XXIV Edition (2013-2014). Pompeu Fabra University.
  • Doctoral Thesis Reading: ‘Radical thoracic irradiation and pulmonary functional study in patients with locally advanced non-small cell lung cancer. Systematic review and prospective case series’ . Qualification of outstanding ‘cum laude’.
  • Doctorate courses: Complutense University of Madrid (1995-1997).
  • She is a researcher in numerous clinical trials, publishing several national and international scientific articles.

Dr. Jose María Oliver

Breast radiology

  • Breast radiologist and specialist in cryoblation of breast lesions in the IVOQA Breast Unit.
  • Degree in Medicine and Surgery from the University of Navarra (1983-1989). Specialisation via MIR in Radiology. Number 289.
  • Specialist in radiology in several renowned hospitals, international reference and pioneer in the application of cryoablation to breast pathology in Spain.
  • Head of the Breast Radiology Section at the Hospital Universitario La Paz.
  • Member of the Spanish Society of Medical Radiology (SERAM) and the Spanish Society of Diagnostic Imaging (SEDIM).

Dr. Jesús Cañete Gómez

General and Digestive Surgery. Oncological Surgery

  • Graduate in Medicine and Surgery from the University of Seville (2000- 2006).
  • Specialist in colon and rectal cancer surgery using a minimally invasive approach.
  • Training in transanal rectal cancer treatment (TAMIS and TaTME).
    Training in minimally invasive surgery at Jackson Memorial Hospital (Miami).
  • Specialist in General Surgery at Viamed Fatima Hospital, Seville (currently).
  • Doctor of Medicine from the University of Seville (‘cum laude’).
  • Associate Professor at the University of Seville Founder of the surgical team Laparoscopic Surgery Seville – MISS (Minimally Invasive Surgical Solutions) – minimally invasive surgical techniques in scheduled and emergency surgery.
  • He has written numerous publications in journals and books and is a member of the Spanish Society of Obesity Surgery (SECO), as well as the Spanish Association of Surgeons (AEC) and the Andalusian Association of Surgeons (ASAC).

Dr. Juan José Segura Sampedro

General and digestive surgery. Oncological Surgery

  • Degree in Medicine and Surgery from the University of Seville. 2003-2009.
  • Specialist in peritoneal carinomatosis.
  • Doctor of Medicine from the University of Seville (‘cum laude’).
  • Oncological Surgeon in the Section of Peritoneal, Retroperitoneal and Soft Parts Oncological Surgery, Department of General and Digestive System Surgery, Hospital Universitario La Paz, Madrid.
  • Associate Professor of Surgery, Faculty of Medicine, University of the Balearic Islands, Palma de Mallorca.
  • 3IP in the Research Group in Advanced Oncological Surgery, m-Health and Innovation in Surgical Technology, Institute for Health Research of the Balearic Islands (IdISBa), Palma de Mallorca.
  • He has written numerous publications in journals and books and is a member of the Spanish Society of Surgical Oncology (SEOQ), the Spanish Society of Coloproctology (AECP), the Spanish Association of Surgeons (AEC), the European Society of Oncological Surgery (ESSO) and the Spanish Group of Peritoneal Oncological Surgery (GECOP).

Pablo Soto

Specialist in sports training for oncology patients

  • Higher Degree in Dietetics (2020-2022)
  • Treatment and rehabilitation of cancer patients

Dr. Gonzalez Larriba

Medical oncology

  • Professor of Medical Oncology at the Complutense University of Madrid
  • Head of the Medical Oncology Section of the Hospital Clínico San Carlos in possession of the European Certificate in Oncology
  • Recognition of 6 six-year research periods + 1 six-year period of knowledge transfer
  • Master in Oncology Services Management by the University of Alcala de Henares
  • Visiting Professor of Oncology at the University of Palermo (Italy)
  • Multiple stays in international centres (Memorial Sloan Kettering Cancer Center, Gustave Roussy Institute, University of Lyon, Princess Margaret Hospital in Toronto, University of Pittsburgh)
  • Maximum recognition of the Professional Career by the Regional Ministry of Health of the Community of Madrid
  • Director of the Master’s Degree in Genitourinary Tumours at the Complutense University of Madrid
  • Founder and member of the Board of Directors of the Spanish Lung Cancer Group, Spanish Genitourinary Tumour Group and Spanish Melanoma Group
  • Member of the Board of Directors of the Spanish Society of Medical Oncology
  • Miembro de la European Society of Medical Oncology, American Society of Clinical Oncology, International Association for the Study od Lung Cancer, etc.
  • Author of more than 300 scientific articles, 400 conference papers and 60 scientific books, as well as speaker in more than 400 conference papers

Francisco Flores

Physiotherapy

  • Graduate in physiotherapy. UEM.
  • Master’s degree in respiratory physiotherapy. UNIVERSITAT
  • ROVIRA i VIRGILI.
  • MASTER specialist in conservative and invasive physiotherapy of myofascial pain syndrome and fibromyalgia. UAH.
  • SPIROMETRIST by the ERS-SEPAR for the performance and interpretation of SPIROMETRY.
  • MASTER Specialist in intratissue percutaneous electrolysis treatments EPI.
  • Specialist in the use and application of the INDIBA ACTIV system.
  • MASTER Specialist in Biomechanical Analysis, Intervention and Treatment “Check yourMOtion”.
  • NATIONAL CLASSIFIER for athletes with cerebral palsy.
  • NATIONAL CLASSIFIER of athletics for people with physical disabilities.
  • RESEARCH PROJECT: “Respiratory physiotherapy as a treatment for ARVC in high performance athletes”.

Dr. Javier Heras Aznar

BREAST UNIT

  • Graduate in Medicine and Surgery from Universidad Autonoma de Madrid 1992.
  • Specialist via MIR in Family Medicine at Hospital Universitario Ramón y Cajal 1994-1996.
  • Specialist via MIR in OBSTETRICS AND GYNECOLOGY at Hospital Universitario Santa Cristina in Madrid 1997-2001.
  • Specialized in the last 27 years in Gynecological Oncology and Breast Pathology, both malignant and benign, with experience in Oncoplastic Surgery.
  • Specialization Course in Oncoplastic Breast Surgery 2015.
  • Coordinator of the Breast Unit and the Breast Tumors and Gynecology Oncology Committee in Hospital Universitario Infanta Sofía.
  • Main Author of the Breast Unit Accreditation Project (Hospital Universitario Infanta Sofía) 2019-2020.

Dr. Beatriz García-Conde

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Puerta de Hierro University Hospital in Majadahonda. Currently working at the 12 de Octubre University Hospital.
  • Specialist in capsule endoscopy and in diagnostic and therapeutic endoscopy: chromoendoscopy, colon cancer screening, digestive dilatations, PEG placement, endoluminal vacuum therapy (fistulas/leaks), polypectomy/mucosectomy.
  • She also a general digestive consultant with a Master’s Degree in Neurogastroenterology.

Dr. Micaela Riat Castro Zocchi

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Princesa Hospital (Madrid).
  • Clinical consultation. Diagnostic and therapeutic endoscopy: Chromoendoscopy, Colon Cancer Screening, Placement of digestive prosthesis (oesophagus, colon), Digestive dilatations, PEG Placement, Endoluminal Vacuum Therapy (fistulas/leaks), Polypectomy/mucosectomy. Experience in Bariatric Endoscopy: Intragastric balloon.

Dr. Diana Fresneda Cuesta

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Jiménez Díaz Foundation. (Madrid)
  • Clinical consultation. Specialist in Endoscopic Capsule and in Diagnostic and Therapeutic Endoscopy: Chromoendoscopy, Colon Cancer Screening, Ligation of Oesophagus Varices, Placement of digestive prosthesis (oesophagus, colon), Digestive dilatations, PEG Placement, Endoluminal Vacuum Therapy (fistulas/leaks), Polypectomy/mucosectomy. Experience in bariatric endoscopy: intragastric balloon, POSE method and Endo-sleeve with POSE system, etc.

Dr. Teresa Valdés Lacasa

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery
  • MIR specialisation in Digestive System Medicine, 12 de Octubre University Hospital (Madrid). Advanced Endoscopy Fellowship (ERCP and digestive prostheses) at Ninewells Hospital (United Kingdom). 2020-2021.
  • Clinical consultation and abdominal ultrasound.
  • Specialist in pancreatico-biliary conditions and therapeutic endoscopy: ERCP, placement of digestive prostheses (oesophagus, duodenum, colon, biliary), digestive dilatations, placement of PEGs, endoluminal vacuum therapy (fistulas/leaks), polypectomy/mucosectomy.

Dr. Andrés J. del Pozo García, MD. PhD.

DUAL SPECIALISATION IN DIGESTIVE SYSTEM MEDICINE / FAMILY AND COMMUNITY MEDICINE

  • Graduate in Medicine and Surgery.
  • Dual specialised training (MIR) at the Princesa University Hospital (Madrid).
  • Specialist in Digestive System Medicine and Specialised in Family and Community Medicine
  • PhD in Medicine from the Autonomous University of Madrid. Cum Laude. 2020.
  • Member of S.E.P.D, S.E.E.D., A.E.G, E.S.G.E, AESPANC, Board Member of GETTEMO; Consultant of Apollo Endosurgery in 2021.

Dr. José María Abadal Villayandre

SPECIALIST IN VASCULAR INTERVENTIONAL RADIOLOGY

  • Graduate in Medicine and Surgery from Navarra University.
  • MIR specialisation in Radiology, Radiodiagnosis at Gregorio Marañón University Hospital.
  • PhD in Radiodiagnosis from the Complutense University of Madrid. Cum Laude Doctoral Thesis.
  • Specialist in Vascular Interventional Radiology, accreditation from the Spanish Society of Interventional Radiology.
  • European Board Interventional Radiology (EBIR) Health Sciences) at Alfonso X el Sabio University. 2010-2014.
  • Medical Director of the “Centro de Radiología y Diagnóstico por Imagen”.
  • Scientific and research activity with numerous publications and research studies.
  • Director and professor of Interventional Vascular Radiology at the I-XI Endo-school. Teaching activity.
  • Member of SERAM (Spanish Society of Medical Radiology), CIRSE (Cardiovascular Interventional Radiology Society Europe), and Secretary of SERVEI (Spanish Society of Interventional Vascular Radiology).

Belén Pérez Peiro. Psychologist

SPECIALIST IN PSYCHO-ONCOLOGY

  • Graduate in Psychology
  • Clinical psychologist, Gregorio Marañón University General Hospital, Psycho-oncology, Gynaecological Psychology, Neuropsychology, Detoxification and Out-patient Hospital, inflammatory bowel disease and teenagers.
  • Clinical activity at the Niño Jesús Children’s University Hospital, Psychiatric and Eating Disorder Units.
  • Expert qualification in Psychosomatic Medicine and Health Psychology.
  • Expert qualification in Psychopathology and Psychiatry from the Spanish Society of Psychosomatic Medicine and Medical Psychology.
  • Specialist qualification in Psychotherapy and projective techniques, both of which are recognised by the Madrid Official Association of Psychologists.

Dr. Ana María Moreno

SPECIALIST IN INTERNAL MEDICINE AND NUTRITIONAL PREHABILITATION

  • Graduate in Medicine and Surgery. 1986– 1992.
  • Extraordinary Graduation Award. 1992.
  • MIR specialisation in Internal Medicine. Number 283.
  • Master’s Degree in Palliative Care from Valladolid University. 2011.
  • University Master’s Degree in Advanced Chronic Nursing and palliative care from Antonio de Nebrija University. 2017.
  • PhD Courses 1993.
  • Extensive professional career in many renowned hospitals.
  • Head of Internal Medicine Services at Viamed Santa Elena (Madrid). September 2021 – Present.
  • Teaching and research work.
  • Numerous publications and papers. Participation in courses and seminars.